Friday, June 7, 2013 at 11:00 a.m.
Douglas Mental Health University Institute
6875 LaSalle Boulevard, Verdun QC H4H 1R3 • Pavilion Douglas Hall

Dr. Christopher C. Rowe, MD, whose research focuses on imaging of neurodegenerative diseases, particularly AD, for better understanding earlier and more accurate detection, and to facilitate development of early therapeutic interventions, will deliver a lecture entitled “Redefining Alzheimer’s Disease – The Role of Molecular Brain Imaging.”
The event takes place at 11 a.m. on Friday, June 7, in the Douglas Mental Health University Institute’s Pavilion Douglas Hall. Learn more here.
For more information : silvana.aguzzi@mcgill.ca
May 23, 2013